about
Precision medicine: from pharmacogenomics to pharmacoproteomicsThe Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityMethylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenesPharmacoepigenetics: an element of personalized therapy?Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patientsAnalysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.Epigenetics in Drug Response.
P2860
Q28076871-B6951456-3453-4752-B5F3-8839FAEDE6F7Q28080256-06FF4A48-8CA1-4B62-A9EF-2EF6D4982C82Q37110909-6A1E6474-A21B-4388-88A5-E7D8952C048EQ39012550-45C16B6B-53F1-4483-9149-008283A13CB7Q41197042-F2C4F4AC-A43A-48E4-8613-4B0C5C498299Q42367899-45BEB195-CDC6-46EB-8698-7BAAD5E49F67Q50179674-A3D081EA-ED3F-4582-A03E-5A353EEC7625Q53151699-CA938339-2179-462F-A943-130DF3D3FFC3
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
DNA Methylation of ADME Genes.
@en
type
label
DNA Methylation of ADME Genes.
@en
prefLabel
DNA Methylation of ADME Genes.
@en
P2093
P2860
P356
P1476
DNA Methylation of ADME Genes.
@en
P2093
P2860
P304
P356
10.1002/CPT.343
P407
P577
2016-02-19T00:00:00Z